Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #4531
Reference
Drug alert no 04/2012
Name
Drug safety information no 4: immediate [Merck Serono - Vigantoletten (1000 IU Colecalciferol) Tablets]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
ALLERGY
SOYA OIL
Description
This unlicensed product is imported in significant quantities into the UK. Although the prescriber must be made aware that Vigantoletten tablets contain soya oil, and are contraindicated for patients with allergies to this ingredient, it has come to the attention of the MHRA that not all users may be aware of these safety issues.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, Health and Healthcare Improvement Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2012-01-23 00:00:00
Click to go back to homepage